Search Within

GSK Faculty

  1. "Tow Center for Developmental Oncology (TCDO) "
Formats
  1. Journal Article (3872)
  2. Meeting Abstract (2644)
  3. Review (123)
  4. Editorial (85)
  5. Book Section (82)
  6. Conference Paper (55)
  7. Research Letter (34)
  8. Miscellaneous (18)
  9. Correspondence (13)
  10. Guidelines (10)
  11. Book Whole (4)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (6940)
  2. Department of Medicine (3462)
  3. Sloan Kettering Institute Faculty (2745)
  4. Human Oncology and Pathogenesis Program (2590)
  5. Department of Pathology and Laboratory Medicine (2569)
  6. Center for Molecular Imaging and Biotechnology (2544)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Cristina Antonescu (894)
  3. Richard O'Reilly (747)
  4. Nai-Kong Cheung (648)
  5. Omar Abdel-Wahab (572)
  6. David Scheinberg (499)

More People

Years
  1. 2025 (89)
  2. 2024 (268)
  3. 2023 (339)
  4. 2022 (358)
  5. 2021 (317)
  6. 2020 (395)

More Years

Publications
  1. Blood (772)
  2. Journal of Clinical Oncology (429)
  3. Modern Pathology (309)
  4. Cancer Research (287)
  5. Laboratory Investigation (266)
  6. Clinical Cancer Research (210)

More Publications

Publishers
  1. Nature Publishing Group (826)
  2. American Society of Hematology (818)
  3. American Association for Cancer Research (678)
  4. Elsevier Inc. (576)
  5. American Society of Clinical Oncology (478)
  6. Nature Research (321)

More Publishers

Results (6940)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Minimally-invasive molecular diagnosis of infiltrating brainstem gliomas through cerebrospinal fluid cell-free DNA sequencing
    Meeting Abstract

    Hill, K.; Giantini-Larsen, A.; Hickman, R. A.; Holle, B. M.; Ucpinar, B. A.; Alano, T.; Doe-Tetteh, S.; DiNapoli, S.; Riviere-Cazaux, C.; Burns, T. C.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • INSIGHT: A phase 3, randomized, open-label study of ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib with KIT exon 11 + 17/18 mutations
    Meeting Abstract

    Zalcberg, J. R.; Blay, J. Y.; Chi, P.; Jones, R. L.; Serrano, C.; Somaiah, N.; Reichmann, W.; Sprott, K.; Cox, P.; Sherman, M. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Cell free DNA (cfDNA) assessment of esophagogastric (EG) cancer using MSK-ACCESS
    Meeting Abstract

    Cytryn, S. L.; Phu, W.; Shah, R. H.; Walch, H. S.; Chatila, W. K.; Vakiani, E.; Brannon, A. R.; Ladanyi, M.; Srivastava, A.; Tang, L. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Investigating hidden influences on treatment for gastrointestinal stromal tumours with AI: Diet, chronic conditions, and mental health – Authors' reply
    Correspondence

    Margonis, G. A.; Bersimas, D.; Singer, S.
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Intratumoral escherichia is associated with improved survival to single-agent immune checkpoint inhibition in patients with advanced non–small-cell lung cancer
    Journal Article

    Elkrief, A.; Montesion, M.; Sivakumar, S.; Hale, C.; Bowman, A. S.; Begüm Bektaş, A.; Bradic, M.; Kang, W.; Chan, E.; Gogia, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Aberrant pre-mRNA processing in cancer
    Review

    Biswas, J.; Boussi, L.; Stein, E.; Abdel-Wahab, O.
    Journal of Experimental Medicine (2024)

    Fulltext@MSK | Save
  • Precursor central memory versus effector cell fate and naïve CD4+ T cell heterogeneity
    Journal Article

    Deep, D.; Gudjonson, H.; Brown, C. C.; Rose, S. A.; Sharma, R.; Iza, Y. A. P.; Hong, S. H.; Hemmers, S.; Schizas, M.; Wang, Z. M.; more...
    Journal of Experimental Medicine (2024)

    Fulltext@MSK | Save
  • Combination of MDM2 and targeted kinase inhibitors results in prolonged tumor control in lung adenocarcinomas with oncogenic tyrosine kinase drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Smith, R. S.; Vojnic, M.; Hayashi, T.; Khodos, I.; Markov, V.; Liu, Z.; Lui, A. J. W.; Bloom, J. L.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Dotting out AML by targeting fibrillarin
    Editorial

    Luo, H.; Kharas, M. G.
    Cancer Research (2024)

    Fulltext@MSK | Save
  • Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: A phase 1b/2a trial
    Journal Article

    Horwitz, S. M.; Nirmal, A. J.; Rahman, J.; Xu, R.; Drill, E.; Galasso, N.; Ganesan, N.; Davey, T.; Hancock, H.; Perez, L.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save